Adeagbo BA - Search Results

1

Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?

Adehin A, Adeagbo BA, Kennedy MA, Bolaji OO, Olugbade TA, Bolarinwa RA, Durosinmi MA. Adehin A, et al. Among authors: adeagbo ba. Leuk Lymphoma. 2019 Jan;60(1):216-221. doi: 10.1080/10428194.2018.1466291. Epub 2018 May 9. Leuk Lymphoma. 2019. PMID: 29741432

2

Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.

Olagunju A, Bolaji OO, Amara A, Waitt C, Else L, Soyinka J, Adeagbo B, Adejuyigbe E, Siccardi M, Back D, Owen A, Khoo S. Olagunju A, et al. J Antimicrob Chemother. 2015 Feb;70(2):555-61. doi: 10.1093/jac/dku420. Epub 2014 Oct 17. J Antimicrob Chemother. 2015. PMID: 25326089 Free PMC article.

3

Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.

Adeagbo BA, Bolaji OO, Olugbade TA, Durosinmi MA, Bolarinwa RA, Masimirembwa C. Adeagbo BA, et al. J Clin Pharm Ther. 2016 Oct;41(5):546-51. doi: 10.1111/jcpt.12424. Epub 2016 Jul 18. J Clin Pharm Ther. 2016. PMID: 27426203

4

Quality of artemisinin-based antimalarial drugs marketed in Nigeria.

Izevbekhai O, Adeagbo B, Olagunju A, Bolaji O. Izevbekhai O, et al. Trans R Soc Trop Med Hyg. 2017 Feb 1;111(2):90-96. doi: 10.1093/trstmh/trx019. Trans R Soc Trop Med Hyg. 2017. PMID: 28460126

5

Population Pharmacokinetics of Imatinib in Nigerians With Chronic Myeloid Leukemia: Clinical Implications for Dosing and Resistance.

Adeagbo BA, Olugbade TA, Durosinmi MA, Bolarinwa RA, Ogungbenro K, Bolaji OO. Adeagbo BA, et al. J Clin Pharmacol. 2017 Dec;57(12):1554-1563. doi: 10.1002/jcph.953. Epub 2017 Jun 15. J Clin Pharmacol. 2017. PMID: 28618035

6

Bidirectional Pharmacokinetic Interaction Between Amodiaquine and Pioglitazone in Healthy Subjects.

Edema O, Adeagbo BA, Adehin A, Olugbade TA. Edema O, et al. Among authors: adeagbo ba. J Clin Pharmacol. 2018 Aug;58(8):1061-1066. doi: 10.1002/jcph.1108. Epub 2018 Apr 17. J Clin Pharmacol. 2018. PMID: 29663414

7

Moringa oleifera leaf powder alters the pharmacokinetics of amodiaquine in healthy human volunteers.

Olawoye OS, Adeagbo BA, Bolaji OO. Olawoye OS, et al. Among authors: adeagbo ba. J Clin Pharm Ther. 2018 Oct;43(5):626-632. doi: 10.1111/jcpt.12725. Epub 2018 Jun 19. J Clin Pharm Ther. 2018. PMID: 29920710

8

Pharmacogenomics in the Nigerian population: the past, the present and the future.

Bolaji OO, Adehin A, Adeagbo BA. Bolaji OO, et al. Among authors: adeagbo ba. Pharmacogenomics. 2019 Aug;20(12):915-926. doi: 10.2217/pgs-2019-0046. Pharmacogenomics. 2019. PMID: 31453771 Review.

9

Influence of MAMA decoction, an Herbal Antimalarial, on the Pharmacokinetics of Amodiaquine in Mice.

Adepiti AO, Adeagbo BA, Adehin A, Bolaji OO, Elujoba AA. Adepiti AO, et al. Among authors: adeagbo ba. Eur J Drug Metab Pharmacokinet. 2020 Feb;45(1):81-88. doi: 10.1007/s13318-019-00583-7. Eur J Drug Metab Pharmacokinet. 2020. PMID: 31642009

10

Influence of selected polymorphisms in disposition genes on lumefantrine pharmacokinetics when coadministered with efavirenz.

Adegbola AJ, Rana A, Adeagbo BA, Bolarinwa RA, Olagunju AE, Siccardi M, Owen A, Bolaji OO. Adegbola AJ, et al. Among authors: adeagbo ba. Pharmacogenet Genomics. 2020 Jul;30(5):96-106. doi: 10.1097/FPC.0000000000000401. Pharmacogenet Genomics. 2020. PMID: 32209837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters